Skip to main content Accessibility help
×
Home

Moclobemide Versus Clomipramine in Endogenous Depression: A Double-Blind Randomised Clinical Trial

  • J. D. Guelfi (a1), C. Payan (a2), J. Fermanian (a3), A. M. Pedarriosse (a4) and R. Manfredi (a4)...

Abstract

The effects of moclobemide (300–600 mg/day), a reversible monoamine oxidase inhibitor – A (MAOI-A), were compared in a double-blind, multi-centre trial with those of clomipramine (100–200 mg/day) on 129 in-patients suffering from endogenous depression (according to ICD–9 and the Newcastle Scale). No significant differences in efficacy were seen between the two treatment groups. In the moclobemide group the mean scores on the MADRS were 36.4 on day 0 and 13.2 on day 42 (end-point analysis); scores were 37.4 and 10.9 respectively in the clomipramine group. An earlier onset of antidepressant activity was noted for moclobemide. Tolerability was significantly better for moclobemide, as shown by the Clinical Global Impression of Tolerance (CGIT). Anticholinergic effects, weight gain and orthostatic hypotension were more frequent in the clomipramine group. No biological treatment-related changes were observed.

Copyright

References

Hide All
American Psychiatric Association (1980) Diagnostic and Statistical Manual of Mental Disorders (3rd edn) (DSM–III). Washington, DC: APA.
Andreasen, N. C., Grove, W. M. & Maurer, R. (1980) Cluster analysis and the classification of depression. British Journal of Psychiatry, 137, 256265.
Andreasen, N. C., Scheftner, W., Reich, T., et al (1986) The validation of the concept of endogenous depression. Archives of General Psychiatry, 43, 246251.
Baumhackl, U., Biziere, K., Fischbach, R., et al (1989) Efficacy and tolerability of moclobemide compared with imipramine in depressive disorder (DSM–III): An Austrian double-blind, multi-centre study. British Journal of Psychiatry, 155 (suppl. 6), 7883.
Blackwell, B., Marley, E., Price, J., et al (1967) Hypertensive interactions between monoamine oxidase inhibitors and foodstuffs. British Journal of Psychiatry, 113, 349365.
Berlin, I., Zimmer, R., Cournot, A., et al (1989) Determination and comparison of the pressor effect of tyramine during long term moclobemide and tranylcypromine treatment in healthy volunteers. Clinical Pharmacology and Therapeutics, 46, 344351.
British Medical Research Council (1965) Clinical trial of the treatment of depressive illness. British Medical Journal, i, 881886.
Burkard, W. P., Bonetti, E. P., Da Prada, M., et al (1989) Pharmacological profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A. Journal of Pharmacology and Experimental Therapeutics, 248, 391399.
Casacchia, M., Carolei, A., Barba, C., et al (1984) A placebo-controlled study of the antidepressant activity of moclobemide, a new MAO-A inhibitor. Pharmacopsychiatry, 17, 122125.
Commission of the European Communities (1989) Guidelines of the Quality, Safety and Efficacy of Medicinal Products for Human Use, no. 3, pp. 210 211 Brussels: CEC.
Da Prada, M., Kettler, R., Keller, H. H., et al (1989) Neurochemical profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A. Journal of Pharmacology and Experimental Therapeutics, 248, 401414.
Derogatis, L. R. (1977) SCL 90–R: Administration, Scoring and Procedure. Manual I. Baltimore, MD: Johns Hopkins.
Dixon, W. J. (1985) BMDP Statistical Software. Berkeley: University of California Press.
Guelfi, J. D., Pull, C. B., Guelfi, C., et al (1983) La CHESS, utilisation dans la pathologic anxieuse et depressive. Structure factorielle. Annates Médico-psychologiques, 141, 257278.
Hamilton, M. (1960) A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 5662.
Hamilton, M. (1967) Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology, 6, 278296.
Hollister, L. E. (1977) Individualised dosage of tricyclic antidepressants. Drugs, 14, 161162.
Larsen, J. K., Holm, P. & Mikkelsen, P. L. (1984) Moclobemide and clomipramine in the treatment of depression. Acta Psychiatrica Scandinavica, 70, 254260.
Montgomery, S. A. & Asberg, M. (1979) A new depression scale designed to be sensitive to change. British Journal of Psychiatry, 134, 382389.
Norman, T. R., Ames, D., Burrows, G. D., et al (1985) A controlled study of a specific MAO-A reversible inhibitor (Ro 11–1163) and amitriptyline in depressive illness. Journal of Affective Disorders, 8, 2935.
Pariente, P., Lepine, J. P., Boulenger, J. P., et al (1989) The Symptom Check-List 90R (SCL-90R) in a French general psychiatric 708 outpatient sample: is there a factor structure? Psychiatry and Psychobiology, 4, 151157.
Paykel, E. S. & White, J. L. (1989) A European study of views on the use of monoamine oxidase inhibitors. British Journal of Psychiatry, 155 (suppl. 6), 917.
Puech, A. J. & Berlin, I. (1990) Moclobemide: Drug and Alcohol Interactions. Kyoto: CINP Congress.
Roth, M., Gurney, C. & Mountjoy, C. G. (1983) The Newcastle rating scales. Acta Psychiatrica Scandinavica (suppl. 310), 4254.
Stefanis, C. N., Alevizos, B. & Papadimitriou, G. (1984) Moclobemide (Ro 11–1163) versus desipramine: a double-blind study in depressive patients. In Monoamine Oxidase and Disease, Prospects for Therapy with Reversible Inhibitors, London: Academic Press.
Versiani, M., Oggero, U., Alterwain, P., et al (1989) A double-blind comparative trial of moclobemide versus imipramine and placebo in major depressive episodes. British Journal of Psychiatry, 155 (suppl. 6), 7277.
Winer, B. J. (1971) Statistical Principles in Experimental Design (2nd edn). New York: McGraw-Hill.
World Health Organization (1978) Mental Disorders: Glossary and Guide to their Classification in Accordance with the Ninth Revision of the International Classification of Diseases (ICD-9). Geneva: WHO.

Related content

Powered by UNSILO

Moclobemide Versus Clomipramine in Endogenous Depression: A Double-Blind Randomised Clinical Trial

  • J. D. Guelfi (a1), C. Payan (a2), J. Fermanian (a3), A. M. Pedarriosse (a4) and R. Manfredi (a4)...

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.

Moclobemide Versus Clomipramine in Endogenous Depression: A Double-Blind Randomised Clinical Trial

  • J. D. Guelfi (a1), C. Payan (a2), J. Fermanian (a3), A. M. Pedarriosse (a4) and R. Manfredi (a4)...
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *